Male breast cancer (MBC) is rare, accounting for less than 1% of all breast cancer but the
incidence has increased worldwide. Risk factors include increased longevity, obesity …

Male breast cancer is a rare disease, of which little is known. In contrast to female breast
cancer, the very vast majority of all cases are positive for estrogen receptor alpha (ERα) …

Male breast cancer (MBC) is rare and poorly characterized. Like the female counterpart,
most MBCs are hormonally driven, but relapse after hormonal treatment is also noted. The …

Male breast cancer (MBC) is rare. We assembled 446 MBCs on tissue microarrays and
assessed clinicopathological information, together with data from 15 published studies …

Objective To comprehensively describe the tumor and clinical characteristics of breast
cancer in a cohort of male patients and to assess the factors that affect survival. Background …

Objective: Describe prognostic parameters of Danish male breast cancer patients (MBCP)
diagnosed from 1980–2009. Determine all-cause mortality compared to the general male …

Breast cancer (BCa) is the second most common cancer worldwide and the most prevalent
cancer in women. The majority of BCa cases are positive (+) for the estrogen receptor (ER+ …

Important differences have begun to emerge concerning the molecular profile of female and
male breast cancer which may prove to be of therapeutic value. This review examined all the …

Male breast cancer (BC) represents an individual subtype of BC, with therapeutic
procedures based on female BC therapy results. The present study evaluated the …

Immunohistochemical profiling studies carried out on female breast cancer has been
extrapolated to breast cancer in males. Although, we do not know if it really reflects the …